Concepedia

Oliver Cohen

OC

Statistics

Publications

25

Citations

2.2K

H-Index

20

Active since

2019

Affiliations

University College London(Current)

The Royal Free Hospital

Amyloidosis Foundation

Boston University

Eastman Dental Hospital

Oliver Cohen is an author at University College London specializing in medicine, pharmacotherapy, and amyloid formation.

Publications per year

2019–2025

25

Publications

25

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib

Richa Manwani, Oliver Cohen, Faye Sharpley et al. · Blood · 2019 · 192 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

1–5 of 25